Phantosmia and Benzodiazepine Withdrawal: A Case Report

Olfactory hallucinations, known as phantosmia, involve the perception of smell without the presence of existing chemical stimuli and are usually described as unpleasant. Other than a single brief mention as one of the symptoms of benzodiazepine withdrawal, olfactory hallucinations are not specifically listed as a symptom of benzodiazepine withdrawal in the common literature. We report the case of an older female with no previous history of psychosis, taking clonazepam for anxiety for five years. She was instructed by her outpatient provider to stop clonazepam before her elective surgery. Due to fear of mixing oxycodone prescribed for postoperative pain, the patient did not resume taking clonazepam during the hospitalization after surgery. No education was provided about benzodiazepine withdrawal or its symptoms. After discharge, she continued to hold clonazepam and started to experience a series of symptoms, such as insomnia, increased sensitivity to smell, and hearing music in her ears. On the day of admission, 14 days after her last clonazepam, she presented with the perception of an unpleasant odor, which she described as "bad" and "evil." Clonazepam was restarted, and all symptoms promptly resolved. To the best of our knowledge, no such case has been reported before. This case illustrates a rare presentation of olfactory hallucinations most likely precipitated by benzodiazepine withdrawal that was completely reversed by restarting the medication. In addition, it emphasizes the importance of providers and patient education regarding safe benzodiazepine discontinuation and raising awareness that olfactory hallucinations may present as a symptom of benzodiazepine withdrawal.

Authors

Institutions

Publication Details

Journal
Cureus
Published
2025-09-12
DOI
https://doi.org/10.7759/cureus.92116
Primary Topic
Olfactory and Sensory Function Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Phantosmia and Benzodiazepine Withdrawal: A Case Report

Miki Kiyokawa, Micaiah C Cape, S. Fong
Cureus
Olfactory and Sensory Function Studies
article

Phantosmia and Benzodiazepine Withdrawal: A Case Report

Miki Kiyokawa, Micaiah C Cape, S. Fong
article en

Abstract

Olfactory hallucinations, known as phantosmia, involve the perception of smell without the presence of existing chemical stimuli and are usually described as unpleasant. Other than a single brief mention as one of the symptoms of benzodiazepine withdrawal, olfactory hallucinations are not specifically listed as a symptom of benzodiazepine withdrawal in the common literature. We report the case of an older female with no previous history of psychosis, taking clonazepam for anxiety for five years. She was instructed by her outpatient provider to stop clonazepam before her elective surgery. Due to fear of mixing oxycodone prescribed for postoperative pain, the patient did not resume taking clonazepam during the hospitalization after surgery. No education was provided about benzodiazepine withdrawal or its symptoms. After discharge, she continued to hold clonazepam and started to experience a series of symptoms, such as insomnia, increased sensitivity to smell, and hearing music in her ears. On the day of admission, 14 days after her last clonazepam, she presented with the perception of an unpleasant odor, which she described as "bad" and "evil." Clonazepam was restarted, and all symptoms promptly resolved. To the best of our knowledge, no such case has been reported before. This case illustrates a rare presentation of olfactory hallucinations most likely precipitated by benzodiazepine withdrawal that was completely reversed by restarting the medication. In addition, it emphasizes the importance of providers and patient education regarding safe benzodiazepine discontinuation and raising awareness that olfactory hallucinations may present as a symptom of benzodiazepine withdrawal.

CureusVol. 17(9)
University of Hawaiʻi at Mānoa (US)
Openalex Percentile: Top 76%
Olfactory and Sensory Function Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Phantosmia and Benzodiazepine Withdrawal: A Case Report — Miki Kiyokawa, Micaiah C Cape, et al. · Cureus (2025) | TGRS Research Map | TGRS